BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KDR, VEGFR2, 3791, ENSG00000128052, P35968, VEGFR, CD309, FLK1 AND Treatment
291 results:

  • 1. Allosteric SHP2 inhibition enhances regorafenib's effectiveness in colorectal cancer treatment.
    Han X; Wang W; Wang R; Zhang W; Zhu L; Xu Q; Guo W; Gu Y
    Biochem Biophys Res Commun; 2024 May; 709():149812. PubMed ID: 38564942
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following vegfr-2 and PD-1 blockade in a colon cancer model.
    Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
    J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating vegfr2 signal pathway in colorectal cancer.
    Wang S; Yang J; Kuang X; Li H; Du H; Wu Y; Xu F; Liu B
    J Ethnopharmacol; 2024 May; 326():117913. PubMed ID: 38360380
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of total coumarins from
    Liu Y; Cheng DH; Su ZY; Lv JH; Wang L; Deng YY; Li L
    Pharm Biol; 2024 Dec; 62(1):153-161. PubMed ID: 38347502
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial.
    Huang WK; Hsu HC; Yang TS; Lu CW; Pan YR; Wu CE; Chung WH; Hung SI; Yeh CN
    Eur J Cancer; 2023 Dec; 195():113286. PubMed ID: 37968194
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights.
    Sohel M
    Phytother Res; 2024 Feb; 38(2):489-506. PubMed ID: 37905329
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Antitumor activity of the new tyrphostin briva against BRAF
    Saleh K; Al Sakhen M; Kanaan S; Yasin S; Höpfner M; Tahtamouni L; Biersack B
    Invest New Drugs; 2023 Dec; 41(6):791-801. PubMed ID: 37870738
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of colorectal cancer.
    Huntington KE; Louie AD; Srinivasan PR; Schorl C; Lu S; Silverberg D; Newhouse D; Wu Z; Zhou L; Borden BA; Giles FJ; Dooner M; Carneiro BA; El-Deiry WS
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446056
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
    Lu G; Wang X; Cheng M; Wang S; Ma K
    Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
    Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
    Molecules; 2023 May; 28(10):. PubMed ID: 37241785
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sequential-delivery nanocomplex for combined anti-angiogenesis and gene therapy against colorectal cancer.
    Jia F; Li Y; Gao Y; Wang X; Lu J; Cui X; Pan Z; Xu C; Deng X; Wu Y
    Int J Pharm; 2023 Apr; 637():122850. PubMed ID: 36990169
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluation of Fruquintinib in the Continuum of Care of Patients with colorectal cancer.
    Lavacchi D; Roviello G; Guidolin A; Romano S; Venturini J; Caliman E; Vannini A; Giommoni E; Pellegrini E; Brugia M; Pillozzi S; Antonuzzo L
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982913
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A phase I dose-escalation study of SYHA1813, a vegfr and CSF1R inhibitor, in patients with recurrent High-Grade Gliomas or Advanced Solid Tumors.
    Kang Z; Li S; Lin Y; Li Y; Mao Y; Zhang J; Lei T; Wang H; Su Y; Yang Y; Qiu J; Li W
    Invest New Drugs; 2023 Apr; 41(2):296-305. PubMed ID: 36884148
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
    Shirvaliloo M
    Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence.
    Duan ZL; Wang YJ; Lu ZH; Tian L; Xia ZQ; Wang KL; Chen T; Wang R; Feng ZY; Shi GP; Xu XT; Bu F; Ding Y; Jiang F; Zhou JY; Wang Q; Chen YG
    Phytomedicine; 2023 Mar; 111():154658. PubMed ID: 36706698
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of approved monoclonal antibody therapy for colorectal cancer.
    Saoudi Gonzalez N; López D; Gómez D; Ros J; Baraibar I; Salva F; Tabernero J; Élez E
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):755-767. PubMed ID: 36582117
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Platelet-derived growth factor (PDGF) cross-signaling via non-corresponding receptors indicates bypassed signaling in colorectal cancer.
    Moench R; Gasser M; Nawalaniec K; Grimmig T; Ajay AK; de Souza LCR; Cao M; Luo Y; Hoegger P; Ribas CM; Ribas-Filho JM; Malafaia O; Lissner R; Hsiao LL; Waaga-Gasser AM
    Oncotarget; 2022 Oct; 13():1140-1152. PubMed ID: 36264073
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. 6 Iodo-delta lactone inhibits angiogenesis in human HT29 colon adenocarcinoma xenograft.
    Romina O; Federico B; Leonardo S; Jennifer M; Carla R; Marina P; Alejandra D; Guillermo J; Lisa T
    Prostaglandins Leukot Essent Fatty Acids; 2022 Nov; 186():102507. PubMed ID: 36244213
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.